v3.25.4
FINANCIAL INSTRUMENTS - Schedule of Income Statement (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Derivatives, Fair Value [Line Items]      
Net sales $ 14,316 $ 14,086 $ 14,198
Cost of sales 11,642 11,438 11,630
Selling, general and administrative expenses - R&D, net 1,304 1,350 1,316
Other comprehensive income (loss) 221 (192) 48
Gain (loss) on cash flow hedging relationships:      
Gain (loss) recognized in other comprehensive income (loss) 9 (2) 59
Gain (loss) reclassified from AOCI to income 0 0 0
Cash Flow Hedging | Foreign exchange contract | Gain (loss) reclassified from AOCI to income      
Derivatives, Fair Value [Line Items]      
Net sales 0 3 0
Cost of sales (5) 33 0
Selling, general and administrative expenses - R&D, net $ (2) $ (1) $ 34